RFA.PR.E Secures $132.2 Million in Latest Series E Funding Round

RFA.PR.E secured $132.2 million in its latest Series E, adding another data point to the Healthcare & Life Sciences funding market.

RFA.PR.E Raises $132.2 million in Funding

RFA Financial Inc. Pfd Shares Series E Revenue Breakdown – NEO:RFA.PR.E. The dividend is payable on July 15, 2026, to common shareholders of record as of the close of business on June 30, 2026.

Investors Behind the Funding

The round was backed by United States. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

RFA.PR.E operates in Healthcare & Life Sciences. RFA.PR.E's financing adds to recent private-market activity.

Strategic Use of Funds

Main content Search Products Community Markets Brokers More EN Get started RFA.

Looking Ahead

RFA Financial Inc. Pfd Shares Series E Revenue Breakdown – NEO:RFA.PR.E

Source reference: original announcement/article.